e-learning
resources
Berlin 2008
Monday, 06.10.2008
Biomarkers and antibiotic treatment of exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction
K. Kolosova, O. Tsvetkova, E. Ilina, M. Atroshkina (Moscow, Russian Federation)
Source:
Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Session:
Biomarkers and antibiotic treatment of exacerbations of COPD
Session type:
Oral Presentation
Number:
2750
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kolosova, O. Tsvetkova, E. Ilina, M. Atroshkina (Moscow, Russian Federation). The role of bacterial pathogens in exacerbation of COPD assessed by microbiological method and polymerase chain reaction. Eur Respir J 2008; 32: Suppl. 52, 2750
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Viral and bacterial etiologies in acute exacerbation of COPD detected using a multiplex real-time polymerase chain reaction
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Real time polymerase chain reaction versus conventional culture method to detect respiratory pathogens in subjects with non-cystic fibrosis bronchiectasis.
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Efficiency of use real-time polymerase chain reaction in differential diagnostics of the tuberculosis and the lung cancer
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
Multiplex real-time polymerase chain reaction is useful in diagnosing pathogens causing community-acquired pneumonia including atypical bacteria and viruses
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Etiologies of acute exacerbation of bronchial asthma in adults by real-time polymerase chain reaction
Source: Annual Congress 2013 –Asthma
Year: 2013
Usefulness of multiplex real-time polymerase chain reaction for diagnosing community acquired pneumonia in Japanese adults
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Does polymerase chain reaction (PCR) increase diagnostic yield in the investigation of community-acquired lower respiratory tract illness (LRTI)?
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001
Comparison of quantitative PCR and quantitative culture for the detection of airway pathogenic bacteria in COPD
Source: International Congress 2014 – Markers
Year: 2014
Is polymerase chain reaction (PCR) an alternative for broncoscopy in patients with sputum smear negative pulmonary tuberculosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004
Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis
Source: Eur Respir J 2007; 30: 508-516
Year: 2007
Detection of
Mycobacterium tuberculosis
in sputum samples using polymerase chain reaction (PCR)
Source: Eur Respir J 2001; 18: Suppl. 33, 496s
Year: 2001
Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases
Source: Eur Respir J 2003; 21: 944-951
Year: 2003
Diagnostic value of polymerase chain reaction (PCR) in the management of pediatric tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 581s
Year: 2002
Assessment of sputum
Mycobacterium tuberculosis
messenger RNA levels in anti-microbial treatment monitoring
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area
Source: Eur Respir J 2004; 23: 446-451
Year: 2004
Rapid detection of major respiratory tract viral infections in acute exacerbation of COPD by highly sensitive multiplex PCR (mPCR)
Source: Annual Congress 2013 –Viral infections
Year: 2013
Identification of causative bacteria in the airways of COPD by a novel semi-quantitative PCR method
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Use of a multiplex real-time PCR for differential diagnosis of respiratory viral infections
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Diagnostic value of high fever to predict polymerase chain reaction (PCR) status in patients with Novel Coronavirus (COVID-19) pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Diagnostic performance of multiplex bacterial PCR in BAL for bacterial pneumonia varies across molecular assays
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept